Novo Nordisk
NVO
#16
Rank
โ‚น41.667 T
Marketcap
โ‚น9,076
Share price
-1.53%
Change (1 day)
12.56%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): โ‚น235.77

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is โ‚น242.36. In 2022 the company made an earnings per share (EPS) of โ‚น184.19 an increase over its 2021 EPS that were of โ‚น168.96.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น235.7728%
2022โ‚น184.199.01%
2021โ‚น168.9615.08%
2020โ‚น146.8214.83%
2019โ‚น127.86-1.68%
2018โ‚น130.044.96%
2017โ‚น123.9031.08%
2016โ‚น94.53-10.33%
2015โ‚น105.4113.91%
2014โ‚น92.544.03%
2013โ‚น88.95-28.81%
2012โ‚น124.95108.9%
2011โ‚น59.8125.59%
2010โ‚น47.6335.01%
2009โ‚น35.27-9.17%
2008โ‚น38.8361.35%
2007โ‚น24.0728.96%
2006โ‚น18.6625.63%
2005โ‚น14.864.17%
2004โ‚น14.2613.55%
2003โ‚น12.5636.87%
2002โ‚น9.18-6.99%
2001โ‚น9.8721.56%
2000โ‚น8.1249.45%
1999โ‚น5.433.78%
1998โ‚น5.2312.15%
1997โ‚น4.6724.74%
1996โ‚น3.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น157.85-34.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น460.76 90.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น336.92 39.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น269.90 11.36%๐Ÿ‡ซ๐Ÿ‡ท France